User profiles for Dov Hershkovitz

Dov Hershkovitz

Institute of Pathology, Tel-Aviv Medical Center
Verified email at tlvmc.gov.il
Cited by 3214

What are melanocytes really doing all day long…?

…, AL Kadekaro, D Hershkovitz… - Experimental …, 2009 - Wiley Online Library
Everyone knows and seems to agree that melanocytes are there to generate melanin – an
intriguing, but underestimated multipurpose molecule that is capable of doing far more than …

Fetal programming of adult kidney disease: cellular and molecular mechanisms

D Hershkovitz, Z Burbea, K Skorecki… - Clinical Journal of the …, 2007 - journals.lww.com
The role of the kidney in the pathogenesis of hyperten-sion has long been established,
although recent studies challenge renal hegemony and suggest an important role for vascular …

Collagenase nanoparticles enhance the penetration of drugs into pancreatic tumors

…, J Shainsky-Roitman, Y Binenbaum, D Hershkovitz… - ACS …, 2019 - ACS Publications
Overexpressed extracellular matrix (ECM) in pancreatic ductal adenocarcinoma (PDAC)
limits drug penetration into the tumor and is associated with poor prognosis. Here, we …

Head-to-head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a …

…, O Shamni, G Gitstein, D Hershkovitz… - Journal of Nuclear …, 2020 - Soc Nuclear Med
18 F-PSMA-1007 is a novel prostate-specific membrane antigen (PSMA)–based
radiopharmaceutical for imaging prostate cancer (PCa). The aim of this study was to compare the …

Synthetic cells synthesize therapeutic proteins inside tumors

…, M Goldfeder, I Benhar, D Hershkovitz… - Advanced …, 2018 - Wiley Online Library
Synthetic cells, artificial cell‐like particles, capable of autonomously synthesizing RNA and
proteins based on a DNA template, are emerging platforms for studying cellular functions and …

[HTML][HTML] Theranostic barcoded nanoparticles for personalized cancer medicine

…, R Tshuva, E Barak, N Dahan, D Hershkovitz… - Nature …, 2016 - nature.com
Personalized medicine promises to revolutionize cancer therapy by matching the most
effective treatment to the individual patient. Using a nanoparticle-based system, we predict the …

Clonal evolution models of tumor heterogeneity

LI Shlush, D Hershkovitz - American Society of Clinical Oncology …, 2015 - ascopubs.org
Somatic/clonal evolution is the process of sequential acquisition of vertically transmittable
genetic/epigenetic elements in multicellular organisms. Cancer is the result of somatic …

Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease

…, JE Schroeder, D Hershkovitz… - Advanced …, 2023 - Wiley Online Library
Monoclonal antibodies (mAbs) hold promise in treating Parkinson's disease (PD), although
poor delivery to the brain hinders their therapeutic application. In the current study, it is …

68Ga-labeled prostate-specific membrane antigen is a novel PET/CT tracer for imaging of hepatocellular carcinoma: a prospective pilot study

M Kesler, C Levine, D Hershkovitz… - Journal of Nuclear …, 2019 - Soc Nuclear Med
68 Ga-labeled prostate-specific membrane antigen (PSMA), a PET tracer that was recently
introduced for the imaging of prostate cancer, may accumulate in other solid tumors, including …

[PDF][PDF] Macrophage-induced lymphangiogenesis and metastasis following paclitaxel chemotherapy is regulated by VEGFR3

…, M Timaner, Y Mumblat, N Ilan, D Loven, D Hershkovitz… - Cell reports, 2016 - cell.com
While chemotherapy strongly restricts or reverses tumor growth, the response of host tissue
to therapy can counteract its anti-tumor activity by promoting tumor re-growth and/or …